Rajashree Joshi-Hangal is a prominent inventor based in Pleasanton, California. She has made significant contributions to the field of pharmaceuticals, holding a total of 16 patents. Her work focuses on drug formulations and methods for treating various medical conditions, particularly cancer.

Latest Patents

Among her latest patents, Rajashree has developed drug formulations that provide derivatives of decitabine with superior chemical stability and shelf life, while maintaining similar physiological activity. These derivatives are presented in a non-aqueous formulation, which enhances their stability. Additionally, she has patented methods for treating myelodysplastic syndromes, leukemia, and solid tumors using these formulations. Another notable patent involves a method for preparing a lyophilized pharmaceutical composition containing a specific compound or its pharmaceutically acceptable salt. This process includes dissolving the compound in a solvent, such as dimethylsulfoxide, and subsequently removing the solvent through freeze-drying. The resulting lyophilized pharmaceutical compositions are intended for use in medicine, particularly in cancer treatment.

Career Highlights

Rajashree has worked with notable companies in the pharmaceutical industry, including Supergen, Inc. and Astex Pharmaceuticals, Inc. Her experience in these organizations has contributed to her expertise in drug development and formulation.

Collaborations

Throughout her career, Rajashree has collaborated with esteemed colleagues, including Sanjeev Redkar and Ashok Y Gore. These partnerships have further enhanced her innovative work in the pharmaceutical sector.

Conclusion

Rajashree Joshi-Hangal's contributions to drug formulation and cancer treatment exemplify her dedication to advancing medical science. Her numerous patents reflect her innovative spirit and commitment to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.